Novartis Malaria Initiative: best practice example of pharmaceutical industry's engagement in the fight against malaria
Despite considerable advances in the treatment and prevention of malaria, Plasmodium falciparum is still a threat to millions of people across the world, particularly in sub-Saharan Africa, with infants and young children bearing the greatest burden in terms of morbidity and mortality.